Literature DB >> 7771049

Demonstration of Mycoplasma hyorhinis as a possible primary pathogen for porcine otitis media.

T Morita1, H Fukuda, T Awakura, A Shimada, T Umemura, S Kazama, T Yagihashi.   

Abstract

A study of the pathology of the ear was performed on 479 pigs ranging in age from 1 day to 1 year. Histologically, 364 (76.0%) of 479 pigs were affected with otitis. Eustachitis was the most common and preceded an inflammation of other sites of the ear, and an acute eustachitis occurred from as early as 1 week of life. Immunohistochemical examination of frozen cryostat sections revealed Mycoplasma hyorhinis (Mhr) antigens on the luminal surface of the eustachian epithelia in 14 (50.0%) of 28 piglets examined. All the pigs positive for Mhr had an acute eustachitis. Ultrastructural examination on the auditory tubes with positive immunostaining disclosed many mycoplasmas among the cilia. Mhr was isolated from the auditory tubes and tympanic cavities of 19 (67.9%) and 16 (57.1%) of 28 piglets examined, respectively. Porcine otitis media may be caused primarily by Mhr infection in the auditory tube.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7771049     DOI: 10.1177/030098589503200202

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  9 in total

1.  Gene families encoding phase- and size-variable surface lipoproteins of Mycoplasma hyorhinis.

Authors:  C Citti; R Watson-McKown; M Droesse; K S Wise
Journal:  J Bacteriol       Date:  2000-03       Impact factor: 3.490

2.  Optimized protocol for multiplex nested polymerase chain reaction to detect and differentiate Haemophilus parasuis, Streptococcus suis, and Mycoplasma hyorhinis in formalin-fixed, paraffin-embedded tissues from pigs with polyserositis.

Authors:  Ikjae Kang; Duyeol Kim; Kiwon Han; Hwi Won Seo; Yeonsu Oh; Changhoon Park; Jeehoon Lee; Marcelo Gottschalk; Chanhee Chae
Journal:  Can J Vet Res       Date:  2012-07       Impact factor: 1.310

3.  Mycoplasma hyorhinis markedly degrades β-amyloid peptides in vitro and ex vivo: a novel biological approach for treating Alzheimer's disease?

Authors:  Ahsan Habib; Juan Deng; Huayan Hou; Qiang Zou; Brian Giunta; Yan-Jiang Wang; Demian Obregon; Darrell Sawmiller; Song Li; Takashi Mori; Jun Tan
Journal:  Am J Transl Res       Date:  2013-09-25       Impact factor: 4.060

4.  Cholesterol granuloma associated with otitis media and leptomeningitis in a cat due to a Streptococcus canis infection.

Authors:  Sara Van der Heyden; Patrick Butaye; Stefan Roels
Journal:  Can Vet J       Date:  2013-01       Impact factor: 1.008

5.  Invasion of melanoma cells by Mycoplasma hyorhinis: enhancement by protease treatment.

Authors:  Jonathan D Kornspan; Mark Tarshis; Shlomo Rottem
Journal:  Infect Immun       Date:  2009-11-16       Impact factor: 3.441

6.  Oral inoculation of young dairy calves with Mycoplasma bovis results in colonization of tonsils, development of otitis media and local immunity.

Authors:  Fiona Maunsell; Mary B Brown; Joshua Powe; James Ivey; Matthew Woolard; Wees Love; Jerry W Simecka
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

7.  Identification of specific B cell linear epitopes of mycoplasma hyorhinis P37 protein using monoclonal antibodies against baculovirus-expressed P37 protein.

Authors:  Hongzhen Zhu; Yanwu Wei; Liping Huang; Dan Liu; Yongxing Xie; Deli Xia; Haiqiao Bian; Li Feng; Changming Liu
Journal:  BMC Microbiol       Date:  2019-11-05       Impact factor: 3.605

8.  Swine Conjunctivitis Associated with a Novel Mycoplasma Species Closely Related to Mycoplasma hyorhinis.

Authors:  Isabel Hennig-Pauka; Christoph Sudendey; Sven Kleinschmidt; Werner Ruppitsch; Igor Loncaric; Joachim Spergser
Journal:  Pathogens       Date:  2020-12-25

9.  Dysbiosis of Gut Microbiota and Intestinal Barrier Dysfunction in Pigs with Pulmonary Inflammation Induced by Mycoplasma hyorhinis Infection.

Authors:  Yingying Zhang; Yuan Gan; Jia Wang; Zhixin Feng; Zhaoxin Zhong; Hongduo Bao; Qiyan Xiong; Ran Wang
Journal:  mSystems       Date:  2022-06-14       Impact factor: 7.324

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.